33° Sunny

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
- Contact Us
- Subscribe
News
Sports
Features
Classifieds
Obituaries
Subscribe
E-Edition
Community Choice

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

92.41 -1.40 (-1.49%)

Streaming Delayed Price Updated: 3:01 PM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

70 71 Next >

The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial ↗

June 30, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Benzinga Before The Bell: Texas Giga Tesla's Output Ramp Up, California's Lithium Tax, Spot Bitcoin ETF Proposal Rejection And Other Top Financial Stories Thursday, June 30 ↗

June 30, 2022

Reuters Hyundai, Affiliates Plan To Set Up New Company In US:

Via Benzinga

US Government Calls For Additional Doses Of Pfizer/BioNTech COVID-19 Vaccine ↗

June 30, 2022

Via Benzinga

BioNTech Whale Trades Spotted ↗

June 17, 2022

A whale with a lot of money to spend has taken a noticeably bearish stance on BioNTech. Looking at options history for BioNTech (NASDAQ:BNTX) we detected 14 strange trades.

Via Benzinga

Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine

June 29, 2022

From Pfizer Inc.

Via Business Wire

Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline' ↗

June 29, 2022

The Food and Drug Administration’s panel of independent vaccine experts recently voted 19 to 2 to recommend a new batch of COVID-19 booster shots targeting the omicron variant this fall. The news,...

Via Benzinga

Novavax Stock Is in Prime Position For Speculation ↗

June 29, 2022

NVAX stock is on the cusp of the FDA approval that has long eluded the firm, meaning now is the best time to speculate on Novavax.

Via InvestorPlace

Pfizer, Moderna, Novavax Tumble As FDA Experts Consider Omicron Shots ↗

June 28, 2022

A panel of experts will decide whether to recommend omicron-specific boosters.

Via Investor's Business Daily

US Government Offers $75M Support For Lipid Systems Expansion Used In mRNA COVID-19 Vaccines ↗

June 28, 2022

Via Benzinga

Why Pfizer Partner BioNTech Shares Are Rising Today ↗

June 27, 2022

BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by 6.31% at $142.50 after the company announced its Omicron-adapted COVID-19 vaccine candidates demonstrated high immune response against the...

Via Benzinga

The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies ↗

June 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Pfizer/BioNTech's Updated Omicron-Based COVID-19 Shots Show Improved Response Against Variant ↗

June 27, 2022

Via Benzinga

7 Biotech Stocks With Key Catalysts Coming in July ↗

June 27, 2022

Biotech stocks have had a rocky few months, but many are on the mend. These picks should provide investors both flexibility and growth.

Via InvestorPlace

Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron

June 25, 2022

From Pfizer Inc.

Via Business Wire

The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial ↗

June 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

BioNTech Gets EMA's Priority Medicines Status For Testicular Cancer Drug ↗

June 23, 2022

BioNTech (NASDAQ: BNTX) received Priority Medicines (PRIME) designation from the European Medicines Agency (EMA) for its product candidate BNT211 in the third- or later-line treatment of testicular...

Via Benzinga

7 Long-Term Stocks to Buy in a Bear Market ↗

June 20, 2022

These long-term stocks to buy are from defensive sectors, because now is the time to play defense in your stock investing.

Via InvestorPlace

Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Nod For Kids As Young As Six Months ↗

June 17, 2022

Via Benzinga

Pfizer, Moderna Snag FDA OK For Covid Shots In Children At 6 Months Old ↗

June 17, 2022

The decision expands Covid shots out to the last group to become eligible.

Via Investor's Business Daily

Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age

June 17, 2022

From Pfizer Inc.

Via Business Wire

Bavarian Nordic Launches COVID-19 Booster Study To Compare Against Pfizer/BioNTech Shot ↗

June 16, 2022

Via Benzinga

The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK ↗

June 16, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

FDA Committee Backs Pfizer, Moderna COVID-19 Vaccines For Toddlers, Youngest Children ↗

June 16, 2022

The FDA's Vaccines and Related Biological Products Advisory Committee voted i

Via Benzinga

As Omicron Surges, FDA Mulls Pfizer, Moderna Covid Shots For Babies ↗

June 15, 2022

Pfizer studied a three-dose regimen. Moderna looked at two doses.

Via Investor's Business Daily

The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data ↗

June 15, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Morning Brief: Top Financial Stories Dominating on Wednesday, June 15 ↗

June 15, 2022

Reuters Warner Bros Discovery To Undergo Major Global Ad Sales Team Restructuring

Via Benzinga

FDA Committee Backs Moderna's COVID-19 Shot For Kids, Adolescents: Report ↗

June 15, 2022

Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccine received unanimous backing from the FDA's committee of independent immunization experts for children ages 6 through 17.

Via Benzinga

EU Urges Pfizer To Further Delay COVID-19 Vaccine Deliveries: Reuters ↗

June 14, 2022

Via Benzinga

Moderna's COVID-19 Shot Likely Related To Higher Heart Inflammation Risk Than Pfizer's: Reuters ↗

June 14, 2022

Via Benzinga

IBD/TIPP Poll: There's Bad News For Novavax's Covid Vaccine ↗

June 14, 2022

Here's why its protein-based shot could struggle in the U.S.

Via Investor's Business Daily

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

70 71 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard Times

Services

Contact Us
Subscription Services
Promote Your Event
Site Forms
Search

ricentral.com
187 Main Street
Wakefield, RI 02879
Phone: 401-789-9744
Email: news@ricentral.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

BioNTech SE - American Depositary Shares (NQ:BNTX)

All News about BioNTech SE - American Depositary Shares

Sections

Services